Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain

Journal of Neurochemistry

Volumn 77, Issue 4, 2001, Pages 1085-1096

  Reaux, Annabelle ^a   De Mota, Nadia ^a   Skultetyova, Ivana ^a   Lenkei, Zsolt ^a   Messari, Said El ^a   Gallatz, Katalin ^b   Corvol, Pierre ^a   Palkovitst, Miklos ^b   Llorens Cortès, Catherine ^a  

^a INSERM   (France)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Arterial blood pressure; Drinking behaviour; Internalization; Second messenger; Vasopressin release

Indexed keywords

APELIN; ARGINYLLEUCYLSERYLHISTIDYLLYSYLGLYCYLPROLYLMETHIONYLPROLYLPHENYLALANINE; CYCLIC AMP; FORSKOLIN; GLYCYLPROLYLMETHIONYLPROLYLPHENYLALANINE; GREEN FLUORESCENT PROTEIN; LYSYLPHENYLALANYLARGINYLARGINYLGLUTAMINYLARGINYLPROLYLARGINYLLEUCYLSERYLHIS TIDYLLYSYLGLYCYLPROLYLMETHIONYLPROLYLPHENYLALANINE; MESSENGER RNA; NEUROPEPTIDE; PYROGLUTAMYLARGINYLPROLYLARGINYLLEUCYLSERYLHISTIDYLLYSYLGLYCYLPROLYLMETHION YLPROLYLPHENYLALANINE; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY FLUID; CHO CELL; CONTROLLED STUDY; DRUG INHIBITION; FLUID INTAKE; GENE EXPRESSION; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERNALIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; SECOND MESSENGER; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; VASOPRESSIN RELEASE;

AMINO ACID SEQUENCE; ANIMALS; BLOOD PRESSURE; BRAIN; CARRIER PROTEINS; CEREBRAL VENTRICLES; CHO CELLS; CRICETINAE; CYCLIC AMP; DRINKING BEHAVIOR; FORSKOLIN; IN SITU HYBRIDIZATION; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOLECULAR SEQUENCE DATA; NEURONS; PEPTIDE FRAGMENTS; RATS; RATS, INBRED WKY; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; TRANSFECTION; VASOPRESSINS; WATER DEPRIVATION;

ANIMALIA; BOVINAE; CRICETINAE; CRICETULUS GRISEUS; RODENTIA;

EID: 0035015269     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00320.x     Document Type: Article

References (41)

1. Allen A. M., Paxinos G., Song K. F. and Mendelsohn F. A. O. (1992) Localization of angiotensin receptor binding sites in the rat brain, in Handbook of Chemical Neuroanatomy, Vol. 11: Neuropeptide Receptors in the CNS (Björklund A., Hökfelt T. and Kuhars M. J., eds), pp. 1-37. Elsevier. Amsterdam.
2. Awaji T., Hirasawa A., Kataoka M., Shinoura H., Nakayama Y., Sugawara T., Izumi S. and Tsujimoto G. (1998) Real-time optical monitoring of ligand-mediated internalization of alpha1b-adrenoceptor with green fluorescent protein. Mol. Endocrinol. 12, 1099-1111.
3. Barak L. S., Ferguson S. S., Zhang J. and Caron M. G. (1997a) A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J. Biol. Chem. 272, 27497-27500.
4. Barak L. S., Ferguson S. S., Zhang J., Martenson C., Meyer T. and Caron M. G. (1997b) Internal trafficking and surface mobility of a functionally intact beta2-adrenergic receptor-green fluorescent protein conjugate. Mol. Pharmacol. 51, 177-184.
5. Bowers C. Y., Schally A. V., Enzmann F., Boler J. and Folkers K. (1970) Porcine thyrotropin releasing hormone is (pyro)glu-hispro(NH2). Endocrinology 86, 1143-1153.
6. Choe H., Farzan M., Konkel M., Martin K., Sun Y., Marcon L., Cayabyab M., Berman M., Dorf M. E., Gerard N., Gerard C. and Sodroski J. (1998) The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J. Virol. 72, 6113-6118.
7. De Mota N., Lenkei Z. and Llorens-Cortes C. (2000) Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 72, 400-407.
8. Devic E., Rizzoti K., Bodin S., Paquereau L., Knibiehler B. and Audigier Y. (1999) Expression of a new family of receptors similar to CXC chemokine receptors in endothelial cell precursors. Pathol. Biol. (Paris) 47, 330-338.
9. Edinger A. L., Hoffman T. L., Sharron M., Lee B., O'Dowd B. and Doms R. W. (1998a) Use of GPR1, GPRI5, and STRL33 as coreceptors by diverse human immunodeficiency virus type I and simian immunodeficiency virus envelope proteins. Virology 249, 367-378.
10. Edinger A. L., Hoffman T. L., Sharron M., Lee B., Yi Y., Choe W., Kolson D. L., Mitrovic B., Zhou Y., Faulds D., Collman R. G., Hesselgesser J., Horuk R. and Doms R. W. (1998b) An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type I and simian immunodeficiency virus. J. Virol. 72, 7934-7940.
11. Gutkowska J., Antunes-Rodrigues J. and McCann S. M. (1997) Atrial natriuretic peptide in brain and pituitary gland. Physiol. Rev. 77, 465-515.
12. Habata Y., Fujii R., Hosoya M., Fukusumi S., Kawamata Y., Hinuma S., Kitada C., Nishizawa N., Murosaki S., Kurokawa T., Onda H., Tatemoto K. and Fujino M. (1999) Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochem. Biophys. Acta 1452, 25-35.
13. Haley T. J. and McCormick W. G. (1957) Pharmacological effects produced by intracerebral injection of drugs in conscious mouse. Br. J. Pharmacol. 12, 12-15.
14. Hogarty D. C., Speakman E. A., Puig V. and Phillips M. I. (1992) The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin. Brain Res. 586, 289-294.
15. Hohle S., Spitznagel H., Rascher W., Culman J. and Unger T. (1995) Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist. Eur. J. Pharmacol. 275, 277-282.
16. Hosoya M., Kawamata Y., Fukusumi S., Fujii R., Habata Y., Hinuma S., Kitada C., Honda S., Kurokawa T., Onda H., Nishimura O. and Fujino M. (2000) Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J. Biol. Chem. 275, 21061-21067.
17. Imura H., Nakao K. and Itoh H. (1992) The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. Front Neuroendocrinol. 13, 217-249.
18. Kadekaro M., Summy-Long J. Y., Freeman S., Harris J. S., Terrell M. L. and Eisenberg H. M. (1992) Cerebral metabolic responses and vasopressin and oxytocin secretions during progressive water deprivation in rats [published erratum appears in Am. J Physiol. 1992, 262 (6 Part 3): section R following table of contents]. Am. J. Physiol. 262, R310-R317.
19. Lee D. K., Cheng R., Nguyen T., Fan T., Kariyawasam A. P., Liu Y., Osmond D. H., George S. R. and O'Dowd B. F. (2000) Characterization of apelin, the ligand for the APJ receptor. J. Neurochem. 74, 34-41.
20. Lenkei Z., Corvol P. and Llorens-Cortes C. (1995) Comparative expression of vasopressin and angiotensin type-I receptor mRNA in rat hypothalamic nuclei: a double in situ hybridization study. Brain Res. Mol. Brain Res. 34, 135-142.
21. Lenkei Z., Palkovits M., Corvol P. and Llorens-Cortes C. (1997) Expression of angiotensin type-1 (AT1) and type-2(AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol. 18, 383-439.
22. Lenkei Z., Beaudet A., Chartrel N., De Mota N., Irinopoulou T., Braun B., Vaudry H. and Llorens-Cortes C. (2000) A highly sensitive quantitative cytosensor technique for the identification of receptor ligands in tissue extracts. J. Histochem. Cytochem. 48, 1553-1564.
23. McArthur J. C., Hoover D. R., Bacellar H. et al. (1993) Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS cohort study. Neurology 43, 2245-2252.
24. Murphy T. J., Alexander R. W., Griendling K. K., Runge M. S. and Bernstein K. E. (1991) Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351, 233-236.
25. O'Carroll A., Selby T. L., Palkovits M. and Lolait S. J. (2000) Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim. Biophys. Acta 1492, 72-80.
26. O'Dowd B. F., Heiber M., Chan A., Heng H. H., Tsui L. C., Kennedy J. L., Shi X., Petronis A., George S. R. and Nguyen T. (1993) A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136, 355-360.
27. O'Dowd B. F., Nguyen T., Marchese A., Cheng R., Lynch K. R., Heng H. H., Kolakowski L. F. Jr and George S. R. (1998) Discovery of three novel G-protein-coupled receptor genes. Genomics 47, 310-313.
28. Phillips M. I. (1987) Functions of angiotensin in the central nervous system. Annu. Rev. Physiol. 49, 413-435.
29. Reaux A., De Mota N., Zini S., Cadel S., Fournie-Zaluski M. C., Roques B. P., Corvol P. and Llorens-Cortes C. (1999a) PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III. Neuroendocrinology 69, 370-376.
30. Reaux A., Fournie-Zaluski M. C., David C., Zini S., Roques B. P., Corvol P. and Llorens-Cortes C. (1999b) Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc. Natl Acad. Sci. USA 96, 13415-13420.
31. Rucker J., Edinger A. L., Sharron M., Samson M., Lee B., Berson J. F., Yi Y., Margulies B., Collman R. G., Doranz B. J., Parmentier M. and Doms R. W. (1997) Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J. Virol. 71, 8999-9007.
32. Saavedra J. M. (1994) Brain angiotensin Il receptor subtypes, in Angiotensin Receptors (Timmermans P. B. M. W. M. and Saavedra J. M., eds), pp. 151-175. Plenum Press. New York.
33. Seidah N. G. and Chretien M. (1997) Eukaryotic protein processing: endoproteolysis of precursor proteins. Curr. Opin. Biotechnol. 8, 602-607.
34. Shanmuganathan K., Koudriakova T., Nampalli S., Du J., Gallo J. M., Schinazi R. F. and Chu C. K. (1994) Enhanced brain delivery of an anti-HIV nucleoside 2′-F-ara-ddI by xanthine oxidase mediated biotransformation. J. Med. Chem. 37, 821-827.
35. Sibony M., Commo F., Callard P. and Gase J. M. (1995) Enhancement of mRNA in situ hybridization signal by microwave heating. Lab. Invest. 73, 586-591.
36. Tamura T. and Bauer H. (1982) Monoclonal antibody against the carboxy terminal peptide of pp60src of Rous sarcoma virus reacts with native pp60src. Embo J. 1, 1479-1485.
37. Tatemoto K. (2000) Search for an endogenous ligand of the orphan G protein-coupled receptor - discovery of apelin, a novel biologically active peptide. Nippon Rinsho 58, 737-746.
38. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M. X., Kawamata Y., Fukusumi S., Hinuma S., Kitada C., Kurokawa T., Onda H. and Fujino M. (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 251, 471-476.
39. Wright J. W. and Harding J. W. (1992) Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res. Brain Res. Rev. 17, 227-262.
40. Zini S., Fournie-Zaluski M. C., Chauvel E., Roques B. P., Corvol P. and Llorens-Cortes C. (1996) Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc. Natl Acad. Sci. USA 93, 11968-11973.
41. Zou M. X., Liu H. Y., Haraguchi Y., Soda Y., Tatemoto K. and Hoshino H. (2000) Apelin peptides block the entry of human immunodeficiency virus (HIV). FEBS Lett. 473, 15-18.